JD

Jim Dentzer

Chief Executive Officer

Curis

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Curis
Industry
research
Employees
160.0
Seniority
C suite
Annual Revenue
10908000.0

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Google Font API Nginx Google Maps (Non Paid Users) reCAPTCHA Vimeo Mobile Friendly Google Maps Google Tag Manager WordPress.org Remote

Keywords

drug development oncology small molecule immunology biotechnology clinical development hematology biotechnology: biological products (no diagnostic substances) health care biotechnology research cancer therapeutics clinical studies emavusertib irak4 inhibitor fimepinostat ca-170 ca-327 erivedge hematologic malignancies solid tumors fda approval orphan drug designation fast track designation immune checkpoint inhibitors pd-l1 vista tim3 research collaboration compassionate use investigational drugs expanded access preclinical studies phase 1 trials clinical activity treatment options malignancies drug commercialization pharmaceutical partnerships small molecule therapies precision oncology clinical trial enrollment pharmaceutical innovation investigator-initiated trials patient engagement safety & efficacy disease management hedgehog pathway advanced cancer targeted therapies biopharmaceuticals regulatory approval medical research scientific collaboration therapeutic development hospital & health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans